Region Oestergoetland — Clinical Trial Site

142 Registered trials

67 Currently recruiting

Organisation

Region Oestergoetland

Location

Linkoping, Sweden

Identifier

ORG-100010599

Address

Universitetssjukhuset I, 58185, Sweden

Departments

"Linköping University Hospital Renal Medicine Garnisonsvägen 10"
3500:Njurmedicinska kliniken
752001: Hematologiska Kliniken
Allergicentrum
Allergicentrum, Brigadgatan 14
Allergy Centre
Anestesi och intensivvårdskliniken, Linköping
B153 BOND
B153 BOND/Barndagvården onkologi
Barnmottagning, H.K.H. Kronprinsessan Victorias barn- och ungdomssjukhus
Barnonkologen B153 BOND
Barnonkologi, avdelning B153 BOND, H.K.H Universitetssjukhuset Linköping, 5818 85 Linköping
BOND Oncology
Cordinator Medical Service, Linköping
Departement of surgery
Department of Cardiology, Heart Center, 581 85 Linköping, Universitetssjukhuset i Linköping
Department of Cardiothoracic surgery, Heart and Medicine center, 581 85 Linköping, Sweden
Department of Emergency Medicine
Department of Haematology
Department of Health, Medicine and Caring Sciences
Department of Health, Medicine and Caring Sciences (HMV)
Department of hematology
Department of Hematology, O-huset
Department of obestretics and gynecology
Department of Oncology
Department of Ophtalmology
Department of Pulmonology
Department of Rheumatology
Department of Surgery
Dept of Oncology
Dept. Of OB/GYN, University Hospital Linköping,SE-58185 Linköping
Dermatology Department
Endokrinmedicinska kliniken, Universitetssjukhuset Linköping, 581 85 Linköping
Gastroenterology
Gynekologisk onkologi
H.R.H.Crown Princess Victorias Children Hospital
Haematology
Hand and Plastic Surgery
Hematologi
Hematologiska kliniken
Hematologiska kliniken, Universitetssjukhuset, 58185 Linköping
Hematology
Hematology Department
Hjärtkliniken
Hjärtkliniken Norrköping
HKH Kronprinsessan Victorias Barn- och ungdoms sjukhus,
Hudkliniken, Universitetssjukhuset Linköping
Infektionskliniken
Infektionskliniken i Östergötland
Infektionskliniken i Östergötland, Linköpings universitetssjukhus
Kardiologikliniken
Kardiologiska Kliniken
Kardiologkliniken, Garnisonsvägen 10
Kärlsektionen, Thorax-Kärl kliniken, Universitetssjukhuset i Linköping, 58185 Linköping
Kirurgkliniken
Kliniska forskningsenheten, Universitetssjukhuset Linköping
Kliniska prövningsenheten Oncologiska kliniken
Kronprinsessan Victorias barn-och ungdomssjukhus, Universitetssjukhuset i Linköping
Kronprinsessan Viktorias Barnsjukhus
Kvinnokliniken
Kvinnokliniken, Universitetssjukhuset Linköping
Linköping University Hospital Renal Medicine Garnisonsvägen 10 581 85 Linköping
Linköping University Hospital, Linköping, Sweden
Lungkliniken
Lungmedicinska kliniken
Mag-tarmmedicinska kliniken
Magtarmmedicinska kliniken
Magtarmmedicinska kliniken, IBD mottagnignen
Magtarmmedicinska kliniken, IBD mottagningen , Universitetssjukhuset i Linköping
Magtarmmedicinska kliniken, IBD mottagningen, Universitetssjukhuset i Linköping
Nephrology
Neurofysiologiska kliniken, Universitetssjukhuset i Linköping
Njurmedicin mottagningen US
Njurmedicinska kliniken
Njurmedicinska kliniken Linköping
Njurmedicinska kliniken, Mottagning
Njurmedicinska Kliniken, Mottagningen
Njurmedicinska kliniken, Universitetssjukhuset i Linköping
Njurmedicinska kliniken, Universitetssjukhuset i Linkoping, 58185 Linkoping
Ögonkliniken (Ophthalmology)
Oncology
Oncology Department
Onkologiska kliniken
Onkologiska kliniken, Universitetssjukhuset i Linköping
Onkologkliniken
Orthopedi
Pediatric Hematology and Oncology
Pediatric Oncology
Pediatric Oncology center, H.K.H. Kronprinsessan Victoria Children's hospital,Linköping University H
Psykiatricentrum
Psykiatriska kliniken
Psykiatriska kliniken i Linköping
Psykiatriska kliniken i Linköping, Region Östergötland
Region Östergötland
SE10002
SE10003
Surgery
Surgical Department
Thorax-kärlkliniken
undefined
Universitetssjukhuset i Linköping, 581 85 Linköping, Infektionskliniken
Universitetssjukhuset i Linköping, Avd. Obstetrik och Gynekologi, 58185 Linköping
Universitetssjukhuset i Linköping, Linköping
Universitetssjukhuset i Linköping, Onkologiska kliniken
Universitetssjukhuset Linköping Barn- och ungdomskliniken BOND
Vårdcentralen Cityhälsan Centrum, Gamla Lasarettsgatan 18, 602 39 Norrköping
VC Ekholmen, Ekholmsvägen 7, 589 29 Linköping
VC Kärna, Kärnabrunnsgatan 10, 586 62 Malmslätt
Vikbolandet VC, Bygdevägen 13, 610 24 Vikbolandet
Vuxenpsykiatriska kliniken
Ward B153 BOND, HKH Kronprinsessan Victorias barn- och ungdomssjukhus
Z97SE10003:Hematologiska Kliniken

Clinical trials at this site (142)

Search interface

NMDSG-14B2 Recruiting

2024-511651-17-00 Myelodysplastic syndrome 4 2021-09-21
GROINSS-V III Recruiting

2023-508722-99-00 Vulvar cancer 4 2020-11-19
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 atypical teratoid/rhabdoid tumours (ATRT) 5 2020-07-20
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
Stopping anti-TNF treatment in Crohn's and Colitis patients in remission Recruiting

2024-513299-17-00 Ulcerative colitis 6 2017-05-05
MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial Recruiting

2024-515626-92-00 recurrent/progressive medulloblastoma, ependymoma and a 4 2013-10-18
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years Recruiting

2024-518254-16-00 Acute Myeloid Leukemia (Pediatric 0-18 years) 5 2013-03-01
A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High 'Bad' Cholesterol from an Inherited Condition Ended

2025-520520-17-00 Heterozygous familial hypercholesterolaemia 5 2025-09-05
A Study to Compare Risankizumab to Vedolizumab in Adult Subjects With Moderate to Severe Ulcerative Colitis Ended

2024-518998-33-00 Ulcerative Colitis 5 2025-07-23
A trial to learn how safe AZD7798 is and how well it works in adults with ileal Crohn’s disease who have an ileostomy Ended

2024-514407-33-00 Crohn’s Disease and an Ileostomy 4 2024-12-10
ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia Ended

2024-518669-83-00 acute promyelocytic leukemia (APL) in children and adol 4 2024-12-05
A study looking at how effective and safe AZD7798 is in people with Crohn's disease Ended

2023-510487-12-00 Crohn's Disease 4 2024-11-29
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008) Ended

2023-508636-61-00 Crohn’s Disease 5 2024-10-24
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 10 2024-10-09
Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736). An open label randomized phase II trial with durvalumab following Stereotacti… Ended

2024-512439-54-01 Non-small cell lung cancer (NSCLC) 4 2024-07-24
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Ended

2023-508235-31-00 Atopic Dermatitis 5 2024-06-17
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended

2023-506457-38-00 Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
A Phase III Study to assess efficacy, safety, and tolerability of Zibotentan combined with Dapagliflozin, compared to Dapagliflozin, in pati… Ended

2023-504124-26-00 Chronic Kidney Disease and High Proteinuria 5 2024-04-04
EVOLVE-MI Ended

2023-509268-26-00 Dyslipidemia 6 2024-01-08
Phase 3 study of perioperative dostarlimab in participants with untreated T4N0 or stage III dMMR/MSI-H resectable colon cancer Ended

2023-503265-27-00 Participants with Untreated T4N0 or Stage III dMMR/MSI- 5 2023-11-23
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn's Disease Ended

2023-504741-32-00 Moderately to Severely Active Crohn's Disease 4 2022-11-30
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colit… Ended

2023-504743-13-00 Moderately to Severely Active Ulcerative Colitis 4 2022-11-30
This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28